lunes, 10 de junio de 2013

Drug Information Update - FDA Small Business REdI Conference – Registration now OPEN

FDA Division of Drug Information: Know the Moment It Happens
The Division of Drug Information (DDI) is CDER's focal point for public inquiries. We serve the public by providing information on human drug products and drug product regulation by FDA.

The Food and Drug Administration (FDA)
Small Business Regulatory Education for Industry (REdI)   
What: Spring REdI Conference
When: June 19-20, 2013
Where: The Westin Dallas Fort Worth Airport
4545 West John Carpenter Freeway
Irving, TX 75063
Registration is now open. 
Please find updated details and registration information on our Conference webpage
The Regulatory Education for Industry (REdI) Conference is an FDA-led forum that brings together the regulatory educators from FDA’s Center for Drug Evaluation and Research (CDER) and Center for Devices and Radiological Health (CDRH). The goal of this conference is to provide direct, relevant, and helpful information on the key aspects of drug and device regulations. Our intended audience is the small manufacturers of drug and/or device medical products who want to learn about how FDA approaches the regulation of drugs and devices.

Because the regulatory principles of drugs and devices are both similar and different, the REdI Conference features a cross-cutting plenary addressing FDASIA updates as they impact both drugs and devices, as well as individual break-out sessions which focus on the unique issues of drugs and devices. Common themes include:

• Meetings with FDA
• Clinical Studies and Review
• Site Inspections
This event is FREE!
For more information on CDER Small Business Assistance
workshops and webinars visit

No hay comentarios:

Publicar un comentario